Tamar Reshef

1.0k total citations
24 papers, 820 citations indexed

About

Tamar Reshef is a scholar working on Immunology, Hematology and Immunology and Allergy. According to data from OpenAlex, Tamar Reshef has authored 24 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Hematology and 5 papers in Immunology and Allergy. Recurrent topics in Tamar Reshef's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Mast cells and histamine (4 papers) and Cell Adhesion Molecules Research (4 papers). Tamar Reshef is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Mast cells and histamine (4 papers) and Cell Adhesion Molecules Research (4 papers). Tamar Reshef collaborates with scholars based in Israel and United States. Tamar Reshef's co-authors include Yoseph A. Mekori, David Tanné, Moti Haim, Solomon Behar, Uri Goldbourt, Rami Hershkoviz, Valentina Boyko, A Klajman, Pazit Salamon and Adam Mor and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

Tamar Reshef

24 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamar Reshef Israel 16 327 156 136 128 114 24 820
Barbara Maria Colombo Italy 17 389 1.2× 158 1.0× 331 2.4× 135 1.1× 126 1.1× 35 979
Robert M. Strieter United States 15 460 1.4× 206 1.3× 72 0.5× 65 0.5× 152 1.3× 17 1.1k
Richard Herriot United Kingdom 18 245 0.7× 153 1.0× 187 1.4× 118 0.9× 102 0.9× 41 1.1k
Claus B. Andersen Denmark 14 381 1.2× 154 1.0× 149 1.1× 106 0.8× 94 0.8× 28 1.0k
Jean‐Jacques Guillosson France 13 232 0.7× 116 0.7× 70 0.5× 173 1.4× 44 0.4× 19 710
Sylvie Abi-Younes United States 9 386 1.2× 118 0.8× 71 0.5× 348 2.7× 60 0.5× 9 969
Steven Pfau United States 14 490 1.5× 276 1.8× 72 0.5× 78 0.6× 165 1.4× 31 1.1k
Stacy L. Musone United States 10 347 1.1× 291 1.9× 134 1.0× 96 0.8× 141 1.2× 10 1.0k
Yasunori Matsuki Japan 15 221 0.7× 122 0.8× 230 1.7× 61 0.5× 85 0.7× 40 662
Lars Ottosson Sweden 17 495 1.5× 258 1.7× 245 1.8× 107 0.8× 104 0.9× 30 1.0k

Countries citing papers authored by Tamar Reshef

Since Specialization
Citations

This map shows the geographic impact of Tamar Reshef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Reshef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Reshef more than expected).

Fields of papers citing papers by Tamar Reshef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamar Reshef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Reshef. The network helps show where Tamar Reshef may publish in the future.

Co-authorship network of co-authors of Tamar Reshef

This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Reshef. A scholar is included among the top collaborators of Tamar Reshef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Reshef. Tamar Reshef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shefler, Irit, Pazit Salamon, Tamar Reshef, Adam Mor, & Yoseph A. Mekori. (2010). T Cell-Induced Mast Cell Activation: A Role for Microparticles Released from Activated T Cells. The Journal of Immunology. 185(7). 4206–4212. 79 indexed citations
2.
Reshef, Tamar, Yoseph A. Mekori, & Adam Mor. (2009). Differential antinuclear antibodies pattern.. PubMed. 11(2). 123–4. 1 indexed citations
3.
Orion, David, Yvonne Schwammenthal, Tamar Reshef, et al.. (2008). Interleukin‐6 and soluble intercellular adhesion molecule‐1 in acute brain ischaemia. European Journal of Neurology. 15(4). 323–328. 31 indexed citations
4.
Konstantino, Yuval, Jairo Kusniec, Tamar Reshef, et al.. (2007). Inflammatory Biomarkers are not Predictive of Intermediate‐term Risk of Ventricular Tachyarrhythmias in Stable CHF Patients. Clinical Cardiology. 30(8). 408–413. 25 indexed citations
5.
Twito, Orit, Tamar Reshef, & Martin Ellis. (2006). C‐reactive protein level as a predictor of transient vs. sustained anticardiolipin antibody positivity. European Journal Of Haematology. 76(3). 206–209. 2 indexed citations
6.
Ness-Abramof, R., Dan Nabriski, Menachem S. Shapiro, et al.. (2006). Prevalence and Evaluation of B12 Deficiency in Patients with Autoimmune Thyroid Disease. The American Journal of the Medical Sciences. 332(3). 119–122. 44 indexed citations
7.
Tanné, David, Moti Haim, Uri Goldbourt, et al.. (2005). CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease. International Journal of Cardiology. 107(3). 322–326. 19 indexed citations
8.
Haim, Moti, David Tanné, Tamar Reshef, et al.. (2005). Monocyte chemoattractant protein‐1 and recurrent cardiovascular events in patients with stable coronary heart disease. Clinical Cardiology. 28(1). 31–35. 7 indexed citations
9.
Segev, Amit, Martin Ellis, Fani Segev, et al.. (2004). High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. International Journal of Cardiology. 98(3). 421–424. 43 indexed citations
10.
Tanné, David, Moti Haim, Valentina Boyko, et al.. (2003). Prospective Study of <i>Chlamydia pneumoniae</i> IgG and IgA Seropositivity and Risk of Incident Ischemic Stroke. Cerebrovascular Diseases. 16(2). 166–170. 17 indexed citations
11.
Haim, Moti, David Tanné, Alexander Battler, et al.. (2003). Chlamydia pneumoniae and future risk in patients with coronary heart disease. International Journal of Cardiology. 93(1). 25–30. 7 indexed citations
12.
Haim, Moti, David Tanné, Valentina Boyko, et al.. (2002). Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Journal of the American College of Cardiology. 39(7). 1133–1138. 79 indexed citations
13.
Fireman, Elizabeth, et al.. (1999). Secretion of stem cell factor by alveolar fibroblasts in interstitial lung diseases. Immunology Letters. 67(3). 229–236. 25 indexed citations
14.
Bar-Sela, S, Tamar Reshef, & Yoseph A. Mekori. (1999). IgE antithyroid microsomal antibodies in a patient with chronic urticaria. Journal of Allergy and Clinical Immunology. 103(6). 1216–1217. 40 indexed citations
15.
Bhattacharyya, Siba Prasad, et al.. (1998). Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. Journal of Leukocyte Biology. 63(3). 337–341. 81 indexed citations
16.
17.
Achiron, Anat, Raanan Margalit, Rami Hershkoviz, et al.. (1994). Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.. Journal of Clinical Investigation. 93(2). 600–605. 98 indexed citations
18.
Hershkoviz, Rami, Ofer Lider, Dana Baram, et al.. (1994). Inhibition of T cell adhesion to extracellular matrix glycoproteins by histamine: a role for mast cell degranulation products. Journal of Leukocyte Biology. 56(4). 495–501. 13 indexed citations
19.
Mekori, Yoseph A., et al.. (1993). Immunodeficiency and other clinical immunology. Journal of Allergy and Clinical Immunology. 91(3). 817–824. 8 indexed citations
20.
Rabinowich, H, et al.. (1985). Interleukin-2 production and activity in aged humans. Mechanisms of Ageing and Development. 32(2-3). 213–226. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Maria Colombo Breakdown of academic impact, for papers by Robert M. Strieter Breakdown of academic impact, for papers by Richard Herriot Breakdown of academic impact, for papers by Claus B. Andersen Breakdown of academic impact, for papers by Jean‐Jacques Guillosson Breakdown of academic impact, for papers by Sylvie Abi-Younes Breakdown of academic impact, for papers by Steven Pfau Breakdown of academic impact, for papers by Stacy L. Musone Breakdown of academic impact, for papers by Yasunori Matsuki Breakdown of academic impact, for papers by Lars Ottosson
Rankless by CCL
2026